Abstract:A scalable Gut Microbiome‐on‐a‐Chip (GMoC) that faithfully recreates a physiologically relevant dynamic gut‐microbes interface is presented. The GMoC provide a biomimetic 3D gut model (μGut), closely mimicking key features of the intesine and enabling the visualization of gut microbial behaviors, interactions, and their collective influence on gut health and disease through high‐magnification imaging. The GMoC can offer valuable insights into dissecting microbe‐induced pathogenesis and developing microbe‐based therapeutics to enhance overall gut health. While the human gut microbiota has a significant impact on gut health and disease, understanding of the roles of gut microbes, interactions, and collective impact of gut microbes on various aspects of human gut health is limited by the lack of suitable in vitro model system that can accurately replicate gut‐like environment and enable the close visualization on causal and mechanistic relationships between microbial constitutents and the gut. , In this study, we present a scalable Gut Microbiome‐on‐a‐Chip (GMoC) with great imaging capability and scalability, providing a physiologically relevant dynamic gut‐microbes interfaces. This chip features a reproducible 3D stratified gut epithelium derived from Caco‐2 cells (μGut), mimicking key intestinal architecture, functions, and cellular complexity, providing a physiolocially relevant gut environment for microbes residing in the gut. Incorporating tumorigenic bacteria, enterotoxigenic Bacteroides fragilis (ETBF), into the GMoC enable the observation of pathogenic behaviors of ETBF, leading to μGut disruption and pro‐tumorigenic signaling activations. Pre‐treating the μGut with a beneficial gut microbe Lactobacillus spp., effectively prevent ETBF‐mediated gut pathogenesis, preserving the healthy state of the μGut through competition‐mediated colonization resistance. The GMoC holds potential as a valuable tool for exploring unknown roles of gut microbes in microbe‐induced pathogenesis and microbe‐based therapeutic development.

[Advances of gut-on-a-chip for exploring host-microbe interactions]

Gut-on-chip: Recreating human intestine in vitro

Emerging microfluidic gut-on-a-chip systems for drug development

Gut-on-a-chip for disease models

The Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology

Primary exploration of host–microorganism interaction and enteritis treatment with an embedded membrane microfluidic chip of the human intestinal–vascular microsystem

Intestine‐on‐a‐chip for Intestinal Disease Study and Pharmacological Research

Simulator of the Human Intestinal Microbial Ecosystem (SHIME®): Current Developments, Applications and Future Prospects

Microfluidic Gut-on-a-Chip: Fundamentals and Challenges

Recent Advances in Gut‐ and Gut‐Organ‐Axis‐on‐a‐Chip Models

Contributions of the microbiome to intestinal inflammation in a gut-on-a-chip

Advanced gut-on-chips for assessing carotenoid absorption, metabolism, and transport

Establishment and Evaluation of On-Chip Intestinal Barrier Biosystems Based on Microfluidic Techniques

Intestinal Stem Cell-on-Chip to Study Human Host-Microbiota Interaction

Intestine-on-a-chip: Next level in vitro research model of the human intestine

A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip

Microfluidic Organ-on-a-Chip Models of Human Intestine

Dissecting Gut‐Microbial Community Interactions using a Gut Microbiome‐on‐a‐Chip

Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip

Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip